Kenza Health Hub logoGet Started
1 May 2026Injectable drugsSource update: October 2024

Insulin, Short-Acting Injectable: Dosing and Precautions

Short-acting insulin guidance for diabetes and emergency treatment of severe hyperglycaemia.

Also searched as

Short-acting insulin injectableRegular insulin injectable
Prescription under medical supervision

Source reviewed

October 2024

Guide category

Injectable drugs

Safety boundary

Prescription medicine information for clinician-guided use.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Rapid-acting pancreatic antidiabetic hormone.

Indications

  • Diabetes.
  • Emergency treatment of hyperglycaemia, including diabetic ketoacidosis and hyperosmolar hyperglycaemic state.

Forms and strengths, route of administration

  • Solution of 100 IU/ml in a 3 ml pre-filled pen (300 IU/3 ml) for deep SC injection only in the abdomen, thigh, buttock, or arm.
  • Solution of 100 IU/ml in a 10 ml vial (1000 IU/10 ml) for deep SC injection, IV injection with a syringe calibrated in insulin units, or IV infusion.

Dose

Diabetes

  • Child and adult: one SC injection 15 to 30 minutes before a meal, in combination with intermediate-acting insulin.
  • Dosage must be individualized according to need and adapted in the event of physical activity, change in diet, or infection.

Emergency treatment of hyperglycaemia

  • Adult: initial dose of 0.1 IU/kg by IV injection then 0.1 IU/kg/hour by continuous IV infusion.
  • Adapt the protocol to blood glucose levels.
  • See "Insulin: general information".

Contra-indications, adverse effects, precautions

  • In the event of combination with intermediate-acting insulin, always prepare the mix in the syringe immediately before administration and draw the short-acting insulin first, then the intermediate-acting insulin.
  • By IV route, insulin has a very short half-life of around 5 minutes and the effect disappears within 30 minutes of injection.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.